• Skip to content
  • Accessibility help
Skip to content
Sign in
  • Guidance
  • Skip Standards and indicators submenu

    Quality standards

    Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.

    View our quality standards

    • How to use our quality standards
    • The timeline for developing quality standards
    • Help us develop quality standards
    • Selecting and prioritising quality standards topics
    • About quality standards

    Indicators

    Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.

    View list of indicators

    • Learn about the committee that develops indicators
    • About indicators
  • Skip Life sciences submenu

    Life Sciences

    We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.

    View life sciences

    Get support from NICE

    NICE Advice service

    Trusted, unrivalled expertise.

    Make an enquiry

    Contact us to discuss your requirements.

    Innovative Licensing and Access Pathway (ILAP)

    Streamlining patient access to safe, financially sustainable and innovative medicines.

    Learn how we evaluate technologies

    Health technology evaluation and topic selection manuals

    Updated manuals for methods, processes and topic selection.

    Digital health technologies

    Accelerating our efforts to deliver innovation to the health and care system.

    Evidence standards framework

    Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.

    Our guidance programmes

    Ensuring new technologies are clinically effective and offer economic value.

    Register your product

    Non-pharmaceutical

    NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.

    Pharmaceutical

    UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.

    Find published and proposed evaluations

    Diagnostics

    Guidance on measurements and tests used to evaluate a patient's condition.

    Medical technologies

    Guidance on medical technologies put forward to NICE by manufacturers.

    Technology appraisals

    Guidance on new and existing medicines and treatments in the NHS.

    Highly specialised technologies

    Guidance on the use of highly specialised medicines and treatments.

  • British National Formulary (BNF)
  • British National Formulary for Children (BNFC)
  • Clinical Knowledge Summaries (CKS)
  • Skip About submenu

    About

    NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.

    Explore about

    Our programmes

    Learn about the information we produce.

    • Guidance
    • Advice
    • Quality standards
    • Indicators
    • Digital health
    • Topic selection

    Get involved

    • Understand how decisions are made:

      Attend a committee meeting
    • Comment on draft guidance:

      Guidance in consultation
    • Be part of a guidance committee:

      Join a committee
    • Help develop our products:

      Register as a stakeholder
    • Putting you at the heart of our work:

      Public involvement

    What we do

    • Social care
    • Life sciences
    • NICE international
    • Patient safety
    • Shared decision making
    • View all What we do

    Into practice

    • Social care quick guides
    • Measuring the use of NICE guidance
    • Resource planner
    • View all Into practice

    Who we are

    • The board
    • The NICE strategy 2021 to 2026
    • Corporate publications
    • View all Who we are

    • Contact us
    • Jobs

My account

  • Consultation responses
  • Sign in

You are here:

  1. Home

Interventional procedures programme manual

  • NICE process and methods
  • Reference number: PMG28
  • Published:  01 February 2016

Download (PDF)
  • 1 Introduction
  • 2 Key activities of the programme
  • 3 Timings for developing interventional procedures guidance
  • 4 Remit of the programme
  • 5 Notifications to the programme
  • 6 Teams involved in developing interventional procedures guidance
  • 7 Registering an interest
  • 8 Producing a brief
  • 9 Evidence considered by the Committee
  • 10 Advice and commentary
  • 11 The Committee's assessment of efficacy and safety evidence
  • 12 Draft recommendations
  • 13 The consultation process
  • 14 The production of guidance
  • 15 The resolution process
  • 16 Publication, dissemination and surveillance of guidance
  • 17 Transparency
  • 18 Links with other NICE guidance-producing programmes
  • 19 Reviewing and updating interventional procedures guidance
  • 20 Updating the programme manual
  • 21 Stakeholder engagement
  • 22 Glossary
  • 23 Overall process for development of guidance
  • Update information

On this page

  1. 18.1 How the interventional procedures programme works with other guidance-producing programmes at NICE
  2. 18.2 Procedures suitable for inclusion in NICE guidelines
  3. 18.3 Procedures suitable for medical technologies or technology appraisal guidance

18 Links with other NICE guidance-producing programmes

18.1 How the interventional procedures programme works with other guidance-producing programmes at NICE

Sometimes a procedure that appears to be within the remit of the interventional procedures programme is notified to the topic selection process at another part of NICE. If this occurs, the relevant topic selection team forwards the notification to the interventional procedures programme for consideration. In particular, the medical technology evaluation programme is designed to engage with medical technology and diagnostic companies to identify innovative products with potential benefits for patients and the healthcare system. Some of these products may feature in novel interventional procedures, and the programme teams liaise to ensure that procedures fitting the programme's remit in which these products are used are assessed by the interventional procedures programme.

18.2 Procedures suitable for inclusion in NICE guidelines

NICE guidelines place established treatments in the care pathway, and it is therefore generally only appropriate for them to include interventional procedures when a recommendation has been made for use and there is a degree of clinical interest in the procedure.

Procedures with recommendations for use

If the scoping group for a guideline decides that a procedure for which interventional procedures guidance recommends can be used is relevant to its clinical guideline but will not justify a review question, the interventional procedures guidance is referred to in the 'related NICE guidance' section of the guideline.

If the scoping group for a guideline considers that a procedure recommended for use is likely to justify a review question, the procedure's clinical and cost effectiveness is assessed using the NICE guideline programme's normal assessment methods and processes (see chapter 8 of the guideline manual).

Procedures with recommendations for evidence generation

If the guideline committee opinion is that a procedure with a recommendation for evidence generation has become part of mainstream practice and it is appropriate to assess it as part of the NICE guideline, the committee formally notifies the procedure to the interventional procedures programme to allow for potential update of its guidance. If, on reassessment, the procedure changes to a recommendation for use, its clinical and cost effectiveness can be assessed as part of the guidelines process. If, after reassessment by the Committee, the procedure retains its evidence generation recommendation, the NICE guideline will refer to the procedure as 'related NICE guidance'.

Interventional procedures guidance published with other recommendations

Sometimes, when the Committee deems the evidence base insufficient to make a recommendation for use even with evidence generation, the guidance recommends that the procedure should be carried out only in research. Where there is evidence of no efficacy or the procedure is judged to be unsafe, the guidance recommends that the procedure should not be used. As such, they would not normally form part of a review question in a NICE guideline.

Interventional procedures guidance not yet published

If a clinical guideline is already in development when a relevant notification is received, the interventional procedures programme will pass the finalised scope(s) for the relevant procedure(s) to the CCP at NICE. If interventional procedures guidance in development has not been finalised at the time of the clinical guideline consultation, the consultation document is referred to in the 'Related NICE guidance' section of the guideline.

New interventional procedures

When a newly notified procedure has been scoped and it has been agreed that it will be assessed by the interventional procedures programme, and a clinical guideline is already being developed in this area, the procedure will not form part of the clinical guideline (see chapter 8 of the guideline manual).

18.3 Procedures suitable for medical technologies or technology appraisal guidance

It is usually appropriate for the efficacy and safety of procedures to be considered before either the medical technologies or technology appraisals programmes address the value of the devices used in the procedure, or the procedure itself. Among the procedures considered by the interventional procedures programme to be safe and efficacious enough for routine use, there will be a small number that may be suitable for such an evaluation. This is likely to involve, for example, devices that are indicated for a common health problem or where the costs to the healthcare system of introducing the device are very different from those of existing treatments. In these circumstances, the procedure is passed to NICE's Medical Technologies Evaluation Programme to consider the appropriateness of developing further NICE guidance.


Next page 19 Reviewing and updating interventional procedures guidance Previous page 17 Transparency
  • Guidance
  • Standards and indicators
  • Life sciences
  • British National Formulary (BNF)
  • British National Formulary for Children (BNFC)
  • Clinical Knowledge Summaries (CKS)
  • Knowledge resources
  • About NICE
  • Into practice
  • Get involved with NICE
  • Jobs
  • News
  • Newsletters and alerts
  • Contact us
  • Leave feedback
  • Reusing our content
  • NICE UK Open Content Licence
  • Syndicate our content
  • Events
  • Facebook
  • X
  • YouTube
  • LinkedIn
  • Accessibility
  • Freedom of information
  • Glossary
  • Terms and conditions
  • Privacy notice
  • Cookies

© NICE 2025. All rights reserved. Subject to Notice of rights.